Because of its role in cell cycle inhibition and cellular differentiation, abnormal CEBPA function or regulation is often found in acute myeloid leukemia (AML), liver cancer, breast cancer, and lung cancers (Lourenco and Coffer 2017). This evidence concerns the gene CEBPA and acute myeloid leukemia.